Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_assertion type Assertion NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_head.
- NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_assertion description "[The distribution of EGF 61 G/G homozygotes among colorectal cancer patients was more frequent than that in the control group (33.1% versus 11.1%; Odds Ratio [OR]=3.962; 95% Confidence Interval [CI]=2.036-7.708).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_provenance.
- NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_assertion evidence source_evidence_literature NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_provenance.
- NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_assertion SIO_000772 19011936 NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_provenance.
- NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_assertion wasDerivedFrom befree-20140225 NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_provenance.
- NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_assertion wasGeneratedBy ECO_0000203 NP615075.RAZF4DV_cU17kae-d4GWE0NHfcYTGcTa2gdku_cyk2e-E130_provenance.